ETF Inflow Update: JEPQ, TSLA, PLTR, ISRG
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 25 2025
0mins
Source: NASDAQ.COM
JEPQ Share Price Analysis: JEPQ's 52-week low is $44.31 and high is $59.42, with the last trade at $57.16, indicating a stable position within its range.
Understanding ETFs: Exchange traded funds (ETFs) function like stocks, where investors buy and sell "units" that can be created or destroyed based on demand.
Monitoring ETF Flows: Weekly tracking of shares outstanding helps identify ETFs with significant inflows or outflows, impacting the underlying assets.
Disclaimer on Views: The opinions expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ISRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ISRG
Wall Street analysts forecast ISRG stock price to rise
20 Analyst Rating
16 Buy
4 Hold
0 Sell
Strong Buy
Current: 426.010
Low
575.00
Averages
637.32
High
740.00
Current: 426.010
Low
575.00
Averages
637.32
High
740.00
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Leadership: Intuitive Surgical's Da Vinci surgical robot, launched in 2000, has become the global market leader, widely used for various minimally invasive surgeries, ensuring the company's strong competitive advantage in the medical device industry.
- System Installation Growth: In the recent quarter, the number of installed Da Vinci systems reached 11,395, a 12% increase year-over-year, while global procedures grew by 16%, indicating the company's ongoing market expansion and profitability enhancement.
- Diverse Revenue Streams: In the recent quarter, Intuitive Surgical generated $650 million from system sales and $1.6 billion from instrument and accessory sales, demonstrating the sustainability of its business model and future growth potential.
- Future Market Forecast: It is predicted that by 2031, Intuitive Surgical's market capitalization could reach $500 billion, requiring a 200% increase in stock price to about $1,500 per share, reflecting the company's long-term investment value in the surgical robotics sector.
See More
- Market Leadership: Intuitive Surgical's Da Vinci surgical robot has become the global market leader since its launch in 2000, with an installed base now reaching 11,395 systems, reflecting a 12% year-over-year increase, indicating the company's strong foundation and ongoing growth potential in minimally invasive surgery.
- Diverse Revenue Streams: In the recent quarter, Intuitive Surgical generated $650 million from system sales while bringing in $1.6 billion from instruments and accessories, showcasing the sustainability of its business model and the strength of its recurring revenue stream.
- Future Growth Forecast: For Intuitive Surgical to reach a market cap of $500 billion by 2031, its stock would need to rise 200% to about $1,500; considering its revenue nearly doubled over the past five years, maintaining similar growth could lead to annual revenue of $20 billion, enhancing the company's valuation.
- Technological Innovation Driving Growth: The newly launched Da Vinci 5 system features 150 design innovations and significant computing power, expected to improve operating room workflows and enhance surgeon autonomy, thereby driving revenue growth in the upcoming quarters.
See More
- Significant Revenue Growth: Intuitive Surgical reported a 23% year-over-year revenue increase in Q1, reaching $2.77 billion, demonstrating strong performance in the medical device market despite stock price pressures.
- Extended Instrument Lifetimes: The company increased the usage count of five force-feedback tools from six to fifteen, aimed at alleviating supply chain bottlenecks, which, while not impacting revenue per procedure, may enhance hospital adoption of these high-demand tools.
- Enhanced Customer Loyalty: By raising the maximum usage of older standard instruments, which may slightly impact instrument and accessory revenue, the company aims to lower hospital costs and strengthen customer loyalty, with this segment generating $1.69 billion in Q1.
- Market Reaction Analysis: While analysts remain cautious about Intuitive's outlook, Goldman Sachs raised its price target to $558, arguing that the market's reaction to the extended instrument lifetimes reflects a misunderstanding, with expectations for stable revenue growth ahead.
See More
- Instrument Lifetime Adjustments: Intuitive Surgical has increased the lifespan of five force-feedback tools from six to fifteen uses, addressing supply chain bottlenecks and facilitating hospital adoption, despite market fears of revenue impact.
- Revenue Growth Performance: In Q1, Intuitive Surgical's overall revenue grew by 23% year-over-year to $2.77 billion, with earnings per share at $2.28, reflecting strong market performance and resilience.
- Market Reaction Analysis: While some investors viewed the extended lifetimes as a defensive move against competitors, Goldman Sachs argues this is a long-term strategy, supported by historical data showing minimal revenue impact and potential for increased customer loyalty.
- Future Watch Points: Intuitive Surgical's systems performed 847,000 procedures in Q1, a 16% year-over-year increase, but the company faces a premium valuation of over 49 times earnings, necessitating clearer communication on 2027 instrument changes in the upcoming earnings report to alleviate market concerns.
See More
- Importance of Transparency: The SEC is considering a proposal to reduce public company reporting from quarterly to semi-annually, raising significant investor concern as many believe that transparency is crucial for long-term investment success, and reducing reporting frequency could lead to information asymmetry that negatively impacts investment decisions.
- Investor Advocacy: Listeners of Motley Fool Rule Breaker Investing are actively engaging with the SEC to express support for maintaining quarterly reports, emphasizing that transparency is not only key to investment success but also vital for maintaining market fairness, and this collective action could influence the SEC's final decision.
- Personal Investment Stories: An anonymous listener shared how adhering to the principles of Motley Fool Investing has led to his financial freedom, describing how he has been able to help others and support family members, showcasing that the returns from investing extend beyond financial gains to embody social responsibility.
- Education and Responsibility: Another listener highlighted the importance of educating his daughters about investment basics, fostering a sense of responsibility and long-term thinking, which underscores the role of education in achieving financial freedom and promotes overall family financial health.
See More
- Importance of Transparency: The Motley Fool advocates against the SEC's proposal to reduce corporate reporting from quarterly to semi-annually, arguing that this would diminish transparency and increase uncertainty for individual investors, ultimately impacting their decision-making capabilities.
- Investor Success Stories: An anonymous investor shared achievements made by following Foolish principles, including providing memorable experiences for a cancer patient and alleviating financial burdens for children, highlighting the significance of financial freedom and its positive impact on others' lives.
- Investment Habit Sharing: A listener inquired about when to add to winning stocks, and the Motley Fool founder suggested increasing investments when stocks perform well, emphasizing the importance of focusing on winners for long-term gains.
- Education and Financial Freedom: A German police officer discussed how he educates his daughters about investing, instilling a sense of responsibility and long-term thinking, emphasizing that financial security is not just about wealth accumulation but creating opportunities for freedom of choice.
See More









